The UK’s diabetes landscape in the face of tariffs, power shifts and an increasing disease prevalence

Will Brennan

The End of NHS England: What Comes Next?

Yesterday morning, the Prime Minister blindsided most of Westminster and Whitehall when he announced plans to abolish NHS England (NHSE) as part of wider efforts to cut bureaucracy and streamline government.  This is undeniably a watershed moment for the NHS, with decision-making powers shifting back to the Department of Health and Social Care (DHSC) over ...

A Renewed Momentum? The England Rare Diseases Action Plan

Today – on Rare Disease Day – the Government unveiled the England Rare Diseases Action Plan 2025. It marks a key step in maintaining momentum in the care and support of those affected by rare conditions before the UK Rare Diseases Framework expires in 2026. The Rare Diseases Action Plan outlines how the health system

From Patient Centricity to Patient Leadership: Pharma’s New Digital Engagement Frontier

Interview with with Jenny Ousbey, originally published in Pharma IQ, to discuss key findings from OVID’s new report on pharma-patient engagement trends and how social media is reshaping the industry’s approach to patient care. Pharma IQ: The report highlights a shift from patient-centric campaigns to patient-led experiences in pharma communications. What do you think has

Contact.

OVID Health
Office 5.09
1 Lyric Square
London
W6 0NB

+44 (0) 330 111 0255
[email protected]

About.

We’re an award-winning specialist healthcare communications agency and founders of the Patient Advocacy & Centricity Tracker tool, as well as the global Patient Partnership Index.

The Health Change Makers.

OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.
Site by XYCO

OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.

Site by XYCO